In this episode of Updates in Anesthesiology, Dr. Hadzic explores the ongoing role of neuraxial anesthesia in hip fracture surgery following the widely publicized REGAIN and RAGA trials. Despite claims of equivalence between general and neuraxial techniques, Dr. Alexander Stone and colleagues argue that these trials may have lacked the statistical power and mechanistic clarity to support such a conclusion. We break down the clinical benefits of neuraxial anesthesia—like reduced pulmonary complications, VTE risk, and opioid use—and discuss why abandoning it as a default choice could be a misstep. Tune in for practical, evidence-based insights that help anesthesiologists personalize care and keep patient outcomes front and center.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

Neuraxial Anesthesia Isn't Dead: Reclaiming Its Role After REGAIN

Anesthesia Updates